Preservative-Free Nasal Spray Pump Manufacturing in Latin America

Bringing Innovation Closer: A Milestone for Pharmaceutical Manufacturing in Latin America

For more than two decades, Aptar Pharma has partnered with companies across Latin America to help deliver innovative healthcare solutions to patients and consumers. Today, we are bringing advanced manufacturing closer to the people it serves locally.

That commitment inspired a significant milestone for Aptar Pharma and its customers in the region: the successful transfer and commissioning of our Advanced Preservative Free (APF) production line at our manufacturing facility in Berazategui, Argentina. This investment brings APF technology closer to customers in Latin America, strengthening local manufacturing capabilities while providing greater agility, responsiveness, and support both pharmaceutical and consumer healthcare development across the region.

The story behind this achievement is about much more than equipment and technology. It is a story of collaboration, dedication, and a shared vision to make advanced healthcare solutions more accessible.

For years, pharmaceutical manufacturers in Latin America have relied on importing advanced preservative-free drug delivery technologies from outside the region. By establishing local APF production in Argentina, Aptar Pharma is helping customers access a proven technology platform closer to home, reducing lead times and creating a more agile supply chain to support innovation and speed-to-market.

Located south of Buenos Aires, the Berazategui facility serves as Aptar Pharma's industrial hub for Latin America, supplying customers across 15 countries and supporting both consumer healthcare and prescription pharmaceutical markets. The addition of the APF production line further strengthens the site's role as a regional center of excellence for advanced drug delivery solutions.

Helping Customers Meet Growing Market Needs

Across the healthcare industry, demand for preservative-free formulations continues to increase as pharmaceutical companies seek solutions with fewer additives while maintaining product integrity.

Meeting this demand requires more than an innovative formulation. It depends on the delivery system itself.

Aptar Pharma's APF technology is a leading multidose nasal spray dispensing system for preservative-free formulations. Designed to maintain microbiological integrity through mechanical means, it helps pharmaceutical companies develop differentiated healthcare products that respond to evolving patient and consumer expectations.

By manufacturing this technology within Latin America, Aptar Pharma is helping customers accelerate development programs, strengthen supply security, and gain easier access to high-quality preservative-free solutions that can support future product innovation.

Innovation Through a Local-for-Local Approach

The APF line transfer represents more than a regional investment. It reflects Aptar Pharma's broader commitment to bringing proven technologies closer to customers around the world through its local-for-local manufacturing strategy. Recent investments across North America, Asia, and now Latin America demonstrate the company's focus on expanding capacity, strengthening innovation, and supporting customers where they operate.

“This transfer reflects Aptar Pharma’s continued investment in bringing proven technologies closer to customers and patients around the world,” said Julie Pradeilles, President Consumer Healthcare, Aptar Pharma. “By transferring the APF production line to Argentina, we are strengthening our local-for-local manufacturing approach and supporting greater agility for customers in Latin America. This is a strong example of how our global footprint can help expand access to innovative drug delivery solutions where they are needed.”

Watch the video to follow the journey of the APF production line to Argentina and hear firsthand from the teams whose expertise, determination, and commitment are transforming global innovation into local reality.